Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1995
08/15/1995US5441731 Compounds
08/15/1995CA2142411A1 Polysubstituted 3-acylamino-5-phenyl-1,4- benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
08/15/1995CA2141774A1 Venlafaxine in the inducement of cognition enhancement
08/15/1995CA2030178C Transdermal therapeutic system comprising as active component buprenorphine
08/15/1995CA2007480C Use of the active substance azelastine for the control of psoriasis disorders and inflammatory disorders
08/15/1995CA1336715C 8-(4-piperidinyl)-4h-1-benzopyran-4-one derivatives and their use
08/15/1995CA1336711C Lactam derivatives, their preparation and their use as hypotensive agents
08/15/1995CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
08/15/1995CA1336686C Method of inhibiting onset of or treating migraine headache using a thromboxane a- receptor antagonist
08/15/1995CA1336685C Diagnosing and treating viral infections associated with chronic fatigue
08/15/1995CA1336684C Dsrna-based prevention of viral escape
08/15/1995CA1336683C Diagnosis and treatment of double-stranded rna deficiency states
08/15/1995CA1336682C Preparation for treating dental disease
08/15/1995CA1336678C Prophylaxis and treatment of nervous system diseases with melanin
08/12/1995EP0674510A4 Injectable composition.
08/11/1995CA2142070A1 4-amino-1-piperidylbenzoylguanidines
08/10/1995WO1995021380A1 Assay for screening of receptor antagonists
08/10/1995WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995021199A1 Galactomannan products and compositions containing the same
08/10/1995WO1995021198A1 Production and use of 2-o-desulfated heparin to inhibit elastase
08/10/1995WO1995021184A1 Substituted purines and oligonucleotide cross-linking
08/10/1995WO1995021180A1 Substituted lactose derivatives as cell adhesion inhibitors
08/10/1995WO1995021179A1 Endotoxin reduction or removal process
08/10/1995WO1995021177A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
08/10/1995WO1995021175A1 Pharmaceutically active compounds and liposomes, and methods of use therof
08/10/1995WO1995021173A1 Process for the preparation of a salt of clavulanic acid
08/10/1995WO1995021170A1 Antitumour tetracyclic compounds
08/10/1995WO1995021167A1 Triazole derivatives
08/10/1995WO1995021166A1 Triazole derivatives
08/10/1995WO1995021165A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists
08/10/1995WO1995021164A1 Intermediate and process for making
08/10/1995WO1995021163A1 Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
08/10/1995WO1995021162A1 Process for making hiv protease inhibitors
08/10/1995WO1995021160A1 2-mercaptobenzimidazole derivative and antihyperlipemic or antiarteriosclerotic agent containing the same
08/10/1995WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995WO1995020971A1 Therapeutic composition for replacing and/or supplementing body fluids
08/10/1995WO1995020970A1 A process for the preparation of bismuth complexes
08/10/1995WO1995020969A1 Method for preventing keratocyte loss
08/10/1995WO1995020968A1 Prophylatic for domestic animal mastitis
08/10/1995WO1995020967A1 Composition for wound healing, neuron growth and vascularization
08/10/1995WO1995020966A1 Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
08/10/1995WO1995020965A1 Hiv protease inhibitors and intermediates
08/10/1995WO1995020964A1 Oral liquid compositions containing paroxetine resinate
08/10/1995WO1995020962A1 Protease inhibitors
08/10/1995WO1995020961A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light
08/10/1995WO1995020960A2 Dna damaging agents in combination with tyrosine kinase inhibitors
08/10/1995WO1995020959A1 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/10/1995WO1995020958A1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
08/10/1995WO1995020957A1 Process for making avermectin/zein compositions
08/10/1995WO1995020956A1 Anti-tumour medical preparation on the basis of carboplatin and the method of its production
08/10/1995WO1995020955A1 Liquid pharmaceutical compositions comprising thyroid hormones
08/10/1995WO1995020954A1 Tablets containing thyroid hormones
08/10/1995WO1995020953A1 Therapeutic agents containing thyroid hormones
08/10/1995WO1995020952A1 Inhibitors of poly(adp-ribose) synthetase and use thereof to prevent nmda neurotoxicity
08/10/1995WO1995020951A1 Polymeric adamantane analogues
08/10/1995WO1995020950A1 Therapeutic guanidines
08/10/1995WO1995020949A1 Improving glucose tolerance
08/10/1995WO1995020946A1 Bilayered amoxycillin tablets
08/10/1995WO1995020943A1 Oil-in-water emulsions
08/10/1995WO1995017876A3 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps
08/10/1995WO1995015373A3 Inhibition of dna methyltransferase
08/10/1995DE4409569C1 New poly:glycerol poly:ricinoleate ester(s)
08/10/1995DE4404086A1 Solid pharmaceutical or cosmetic compsn. e.g. stick
08/10/1995DE4404085A1 Pharmaceutical and/or cosmetic formulation of treating greasy skin
08/10/1995DE4403989A1 Liq. pharmaceutical or cosmetic compsn. esp. topical soln.
08/10/1995DE4403709A1 Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid A pharmaceutical composition for systemic transdermal administration containing the active substance of morphine-6-glucuronide
08/10/1995CA2212226A1 Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof
08/10/1995CA2211979A1 Tricyclic derivatives and their use as anti-cancer agents
08/10/1995CA2183466A1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
08/10/1995CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995CA2182593A1 Oral liquid compositions containing paroxetine resinate
08/10/1995CA2182485A1 Pharmaceutically active compounds and liposomes, and methods of use thereof
08/10/1995CA2182361A1 Antitumour tetracyclic compounds
08/10/1995CA2182302A1 Therapeutic guanidines
08/10/1995CA2182197A1 Triazole derivatives
08/10/1995CA2182196A1 Triazole derivatives
08/10/1995CA2182192A1 Protease inhibitors
08/10/1995CA2182090A1 Hiv protease inhibitors and intermediates
08/10/1995CA2182038A1 Therapeutic agents containing thyroid hormones
08/10/1995CA2182037A1 Liquid pharmaceutical compositions comprising thyroid hormones
08/10/1995CA2182007A1 Substituted lactose derivatives as cell adhesion inhibitors
08/10/1995CA2181160A1 2-mercaptobenzimidazole derivative and antihyperlipemic or antiarteriosclerotic agent containing the same
08/10/1995CA2180947A1 Process for making hiv protease inhibitors
08/10/1995CA2180860A1 Intermediate and process for making
08/10/1995CA2159706A1 Method for preventing keratocyte loss
08/10/1995CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/09/1995EP0666317A2 Antisense oligonucleotides against HSV-1 and their preparation
08/09/1995EP0666269A2 Nucleoside derivatives and their use as medicaments
08/09/1995EP0666263A1 Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same
08/09/1995EP0666260A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy
08/09/1995EP0666258A1 Indolylcycloaklanylamin- und Indolylcycloalkenylamine derivatives, their preparation and their use as anti-migraine agents
08/09/1995EP0666252A1 Phenyl substituted alkyl carboxylic acid guanidines with perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing the same
08/09/1995EP0666250A1 Derivatives of N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide having neuroprotective and anti-ischemic properties, their preparation and their use, in therapy
08/09/1995EP0666079A1 Remedy for parkinson's disease
08/09/1995EP0666078A2 Nasal spray compositions
08/09/1995EP0666077A1 Anti-mrsa composition
08/09/1995EP0666076A2 Water in oil emulsion containing retinol
08/09/1995EP0665847A1 Cephem compounds, and their pharmaceutical compositions
08/09/1995EP0665846A1 Topoisomerase ii inhibitors and therapeutic uses therefor
1 ... 6994 6995 6996 6997 6998 6999 7000 7001 7002 7003 7004 7005 7006 7007 7008 7009 7010 7011 7012 7013 7014 ... 7860